First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan.

Kota TsuruyaJun KoizumiYuka SekiguchiShun OnoTatsuya SekiguchiTakuya HaraYusuke MishimaYoshitaka AraseShunji HiroseKoichi ShiraishiTatehiro Kagawa

Published in: BMJ open gastroenterology (2023)

TIPS is an effective potential treatment for ascites in patients with tolvaptan refractory condition. In appropriate patients who can tolerate TIPS, the treatment may lead towards renal function improvement.

Keyphrases

emergency department
atrial fibrillation
human health
adverse drug
climate change